1. Home
  2. KLXE vs RVPH Comparison

KLXE vs RVPH Comparison

Compare KLXE & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • RVPH
  • Stock Information
  • Founded
  • KLXE 2018
  • RVPH 2006
  • Country
  • KLXE United States
  • RVPH United States
  • Employees
  • KLXE 1919
  • RVPH N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • RVPH Health Care
  • Exchange
  • KLXE Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • KLXE 83.1M
  • RVPH 88.0M
  • IPO Year
  • KLXE N/A
  • RVPH N/A
  • Fundamental
  • Price
  • KLXE $4.93
  • RVPH $1.87
  • Analyst Decision
  • KLXE Hold
  • RVPH Strong Buy
  • Analyst Count
  • KLXE 1
  • RVPH 5
  • Target Price
  • KLXE $4.50
  • RVPH $11.40
  • AVG Volume (30 Days)
  • KLXE 193.5K
  • RVPH 1.5M
  • Earning Date
  • KLXE 03-05-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • KLXE N/A
  • RVPH N/A
  • EPS Growth
  • KLXE N/A
  • RVPH N/A
  • EPS
  • KLXE N/A
  • RVPH N/A
  • Revenue
  • KLXE $738,000,000.00
  • RVPH N/A
  • Revenue This Year
  • KLXE N/A
  • RVPH N/A
  • Revenue Next Year
  • KLXE $4.79
  • RVPH N/A
  • P/E Ratio
  • KLXE N/A
  • RVPH N/A
  • Revenue Growth
  • KLXE N/A
  • RVPH N/A
  • 52 Week Low
  • KLXE $4.18
  • RVPH $0.60
  • 52 Week High
  • KLXE $9.80
  • RVPH $4.72
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 42.52
  • RVPH 48.62
  • Support Level
  • KLXE $4.51
  • RVPH $1.97
  • Resistance Level
  • KLXE $5.14
  • RVPH $2.14
  • Average True Range (ATR)
  • KLXE 0.40
  • RVPH 0.16
  • MACD
  • KLXE -0.12
  • RVPH -0.01
  • Stochastic Oscillator
  • KLXE 18.67
  • RVPH 40.43

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: